Search

everythinglearnresearchcommunity

for

Search:↓

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Cilostazol may help hair grow and could be a new treatment for hair loss.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Non-obese women with hair loss have higher heart disease risk.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

DGAT1 enzyme helps make diacylglycerols, waxes, and retinyl esters.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Acitretin helped improve hand mobility and skin condition in a patient.

SIRT3 and SIRT7 decrease, while NFATC1 and PDL-1 increase in Androgenetic Alopecia.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Using a gel called Diclofenac can potentially cause hair to grow back in bald spots in older men.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

New treatments for common hair loss are needed.

Stem cell treatment improved life quality and sexual function in women with hair loss.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Clascoterone 1% cream is a promising new treatment for acne.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.